Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Dong Gang West Road No. 199, Lanzhou, 730000, Gansu, China.
Surg Today. 2012 Jul;42(7):613-24. doi: 10.1007/s00595-012-0188-7. Epub 2012 May 13.
It is unclear whether the preoperative administration of oral carbohydrates (CHO) is safe and effective, and therefore we herein evaluated the efficacy and adverse events associated with CHO for elective surgery.
Comprehensive searches were conducted to identify randomized controlled trials (RCTs), which evaluated preoperative CHO for elective surgery. Two reviewers independently selected the trials, extracted data, and assessed the methodological qualities and evidence levels. The data were analyzed by the RevMan 5.0 software program.
CHO increased the insulin and glucose levels on the first day after surgery higher than those in overnight fasting group (fifteen RCTs) and i.v. glucose infusion group (three RCTs). The pooled results of thirteen RCTs showed greater declines in the insulin level at the induction of anesthesia and a smaller increase in the glucose level at the end of surgery, and fewer decreases in the postoperative insulin sensitivity index in the CHO group were observed as compared to the placebo group. No aspiration was observed in any of the included studies.
CHO appears to be safe, and may attenuate postoperative insulin resistance as compared to placebo. However, the quality of most of the published trials has been poor, and the evidence levels for most outcomes were low, so rigorous and larger RCTs are needed in the future.
术前给予口服碳水化合物(CHO)是否安全有效尚不清楚,因此,我们在此评估择期手术中 CHO 的疗效和相关不良事件。
全面检索评价择期手术术前给予 CHO 的随机对照试验(RCT)。两位评审员独立选择试验、提取数据并评估方法学质量和证据水平。采用 RevMan 5.0 软件程序进行数据分析。
CHO 使术后第 1 天的胰岛素和血糖水平高于夜间禁食组(15 项 RCT)和静脉葡萄糖输注组(3 项 RCT)。13 项 RCT 的汇总结果显示,CHO 组在麻醉诱导时胰岛素水平下降幅度更大,手术结束时血糖水平升高幅度更小,术后胰岛素敏感性指数下降幅度也较小,与安慰剂组相比。纳入的研究均未观察到误吸。
与安慰剂相比,CHO 似乎是安全的,并且可能减轻术后胰岛素抵抗。然而,大多数已发表试验的质量较差,大多数结局的证据水平较低,因此未来需要进行严格且更大规模的 RCT。